Current pharmacological treatments for bronchiolitis are useless

Welliver, 1993, The relationship of RSV specific immunoglobulin IgE antibody responses in infancy, recurrent wheezing and pulmonary function at 7–8 years, Pediatr Pulmonology, 15, 19, 10.1002/ppul.1950150104 Fitzgerald, 2004, Bronchiolitis: Assessment and Evidence Based Management, Med J Aust, 180, 399, 10.5694/j.1326-5377.2004.tb05993.x Kellner, 2003, Bronchodilators for bronchiolitis, Cochrane Review Sanchez, 2005, Response to bronchodilator in infants with bronchiolitis can be predicted from wheeze patterns, Respirology, 10, 603, 10.1111/j.1440-1843.2005.00756.x Wainright, 2003, A multicentre randomized double blind controlled trial of nebulized epinephrine in infants with acute bronchiolitis, N Engl J Med, 349, 27, 10.1056/NEJMoa022226 Numa, 2001, Effect of nebulized epinephrine on respiratory mechanics and gas exchange in bronchiolitis, Am J Resp Crit Care Med, 164, 86, 10.1164/ajrccm.164.1.2008090 Hartling, 2005, Epinephrine for bronchiolitis, Cochrane Database of Systematic Reviews Wang, 1992, Bronchodilators for treatment of mild bronchiolitis: a factorial randomized trial, Arch Dis Child, 67, 289, 10.1136/adc.67.3.289 Garrison, 2000, Systemic corticosteroids in infant bronchiolitis: a meta analysis, Pediatrics, 105, E44, 10.1542/peds.105.4.e44 Schuh, 2002, Efficacy of oral dexamethasone in outpatients with acute bronchiolitis, J Pediatr, 140, 27, 10.1067/mpd.2002.120271 Randolph, 2003, Ribavirin for respiratory syncitial virus infection of the lower respiratory tract, The Cochrane Library Lozano, 2002, Bronchiolitis, Clin Evid, 8, 291 1997, Reduction of respiratory syncitial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncitial virus immune globulin prophylaxis. The PREVENT study group, Pediatrics, 99, 93, 10.1542/peds.99.1.93 1998, Palivizumab, a humanized respiratory syncitial virus monoclonal antibody, reduces hospitalization from respiratory syncitial virus infection in high risk infants. The IMpact RSV study group, Pediatrics, 102, 531, 10.1542/peds.102.3.531 HarkenseeC, 2006, Passive immunization of preterm infants with palivizumab against RSV infection, J Infection, 52, 2, 10.1016/j.jinf.2005.08.003 Bisgaard, 2003, Montelukast in RSV bronchiolitis, Am J Resp Crit Care Med, 169, 542, 10.1164/ajrccm.169.4.952 Curran, 2004, Cetirizine:a revierw of its use in allergic diseases, Drugs, 64, 503, 10.2165/00003495-200464050-00008